176 related articles for article (PubMed ID: 28894380)
1.
Wang J; Liu X; Yan C; Liu J; Wang S; Hong Y; Gu A; Zhao P
Onco Targets Ther; 2017; 10():4251-4260. PubMed ID: 28894380
[TBL] [Abstract][Full Text] [Related]
2. LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2.
Zeng S; Zhou C; Yang DH; Xu LS; Yang HJ; Xu MH; Wang H
Brain Res; 2020 Jun; 1736():146781. PubMed ID: 32184164
[TBL] [Abstract][Full Text] [Related]
3. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
5. Novel LncRNA OXCT1-AS1 indicates poor prognosis and contributes to tumorigenesis by regulating miR-195/CDC25A axis in glioblastoma.
Zhong C; Yu Q; Peng Y; Zhou S; Liu Z; Deng Y; Guo L; Zhao S; Chen G
J Exp Clin Cancer Res; 2021 Apr; 40(1):123. PubMed ID: 33832517
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LEF1-AS1 regulates the migration and proliferation of vascular smooth muscle cells by targeting miR-544a/PTEN axis.
Zhang L; Zhou C; Qin Q; Liu Z; Li P
J Cell Biochem; 2019 Sep; 120(9):14670-14678. PubMed ID: 31016789
[TBL] [Abstract][Full Text] [Related]
7. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of LEF1-AS1 regulating HUVEC cells by targeting miR-489-3p/S100A11 axis.
Zhang H; Wang W; Lin J; Qiao J; Wang X; Fang B; Chen C; Wang Y; Zhu G; Liu W
PeerJ; 2023; 11():e16128. PubMed ID: 37927791
[TBL] [Abstract][Full Text] [Related]
11. LncRNA LEF1-AS1 Promotes Ovarian Cancer Development Through Interacting with miR-1285-3p.
Zhang Y; Ruan F
Cancer Manag Res; 2020; 12():687-694. PubMed ID: 32099465
[TBL] [Abstract][Full Text] [Related]
12. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis.
Sun T; Liu Z; Zhang R; Ma S; Lin T; Li Y; Yang S; Zhang W; Wang Y
Onco Targets Ther; 2020; 13():2957-2972. PubMed ID: 32308428
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p.
Lin H; Zuo D; He J; Ji T; Wang J; Jiang T
Oncol Res; 2021 Mar; 28(6):591-603. PubMed ID: 32838835
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MNX1-AS1 Promotes Glioblastoma Progression Through Inhibition of miR-4443.
Gao Y; Xu Y; Wang J; Yang X; Wen L; Feng J
Oncol Res; 2019 Feb; 27(3):341-347. PubMed ID: 29678219
[TBL] [Abstract][Full Text] [Related]
16. LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway.
Li W; Yang G; Yang D; Li D; Sun Q
Cancer Cell Int; 2020 Nov; 20(1):543. PubMed ID: 33292271
[TBL] [Abstract][Full Text] [Related]
17. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis.
Cheng Y; Wu J; Qin B; Zou BC; Wang YH; Li Y
Biochem Biophys Res Commun; 2020 Jun; 526(3):678-684. PubMed ID: 32248974
[TBL] [Abstract][Full Text] [Related]
18. LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia.
Du X; Liu H; Yang C; Shi X; Cao L; Zhao X; Miao Y; Zhu H; Wang L; Xu W; Li J; Fan L
Leuk Res; 2021 Nov; 110():106706. PubMed ID: 34563944
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MATN1-AS1 prevents glioblastoma cell from proliferation and invasion via RELA regulation and MAPK signaling pathway.
Han N; Yang L; Zhang X; Zhou Y; Chen R; Yu Y; Dong Z; Zhang M
Ann Transl Med; 2019 Dec; 7(23):784. PubMed ID: 32042800
[TBL] [Abstract][Full Text] [Related]
20. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
